JP2014530627A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014530627A5 JP2014530627A5 JP2014537358A JP2014537358A JP2014530627A5 JP 2014530627 A5 JP2014530627 A5 JP 2014530627A5 JP 2014537358 A JP2014537358 A JP 2014537358A JP 2014537358 A JP2014537358 A JP 2014537358A JP 2014530627 A5 JP2014530627 A5 JP 2014530627A5
- Authority
- JP
- Japan
- Prior art keywords
- melanoma
- cell
- vaccine
- cells
- apoptotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161549681P | 2011-10-20 | 2011-10-20 | |
| US61/549,681 | 2011-10-20 | ||
| US201261594304P | 2012-02-02 | 2012-02-02 | |
| US61/594,304 | 2012-02-02 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014530627A JP2014530627A (ja) | 2014-11-20 |
| JP2014530627A5 true JP2014530627A5 (https=) | 2016-02-25 |
Family
ID=48141460
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014537358A Pending JP2014530627A (ja) | 2011-10-20 | 2012-10-22 | 抗原提示癌ワクチン |
| JP2014537355A Pending JP2014533938A (ja) | 2011-10-20 | 2012-10-22 | γインターフェロンを用いた抗原提示癌ワクチン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014537355A Pending JP2014533938A (ja) | 2011-10-20 | 2012-10-22 | γインターフェロンを用いた抗原提示癌ワクチン |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20140308316A1 (https=) |
| EP (2) | EP2768519A4 (https=) |
| JP (2) | JP2014530627A (https=) |
| KR (2) | KR20150016200A (https=) |
| CN (5) | CN105999249A (https=) |
| AU (2) | AU2012325758A1 (https=) |
| CA (2) | CA2852960A1 (https=) |
| HK (2) | HK1201175A1 (https=) |
| IL (2) | IL232172A0 (https=) |
| SG (4) | SG11201401631VA (https=) |
| WO (2) | WO2013059784A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2865830B1 (fr) | 2004-01-30 | 2006-05-19 | Neopost Ind | Systeme d'affranchissement de courrier a mode d'impression externe securise |
| AU2012325758A1 (en) * | 2011-10-20 | 2014-04-24 | Neostem Oncology, Llc | Antigen presenting cancer vaccine with gamma interferon |
| CN103599528B (zh) * | 2013-12-04 | 2015-08-05 | 深圳市合一康生物科技股份有限公司 | 人树突状细胞疫苗的制备方法 |
| CN107109365A (zh) * | 2014-07-17 | 2017-08-29 | 布莱恩·J·赫尔尼奇 | 多剂量注射用树突状细胞疫苗的制备及用于阻断her2和her3的联合治疗 |
| CN109416925A (zh) * | 2016-05-05 | 2019-03-01 | 南托米克斯有限责任公司 | 检查点失效和使检查点失效的方法 |
| AU2018222737B2 (en) * | 2017-02-17 | 2021-03-25 | Aivita Biomedical, Inc. | Methods to enhance tumor immunogenicity and compositions for autologous cancer immunotherapeutic products using modified tumor cells and modified dendritic cells |
| WO2024107624A1 (en) * | 2022-11-14 | 2024-05-23 | Shattuck Labs, Inc. | Methods of overcoming resistance to checkpoint inhibitor therapies |
| CN118441033B (zh) * | 2024-04-24 | 2025-06-20 | 广西医科大学 | HLA-DPB1*05:01在抗γ干扰素自身抗体所致获得性免疫缺陷筛查中的应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2105618C (en) * | 1992-09-07 | 2009-11-03 | Kazuyasu Nakamura | Humanized antibodies to ganglioside gm2 |
| US5874560A (en) * | 1994-04-22 | 1999-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Melanoma antigens and their use in diagnostic and therapeutic methods |
| EP1056834A2 (en) | 1998-02-20 | 2000-12-06 | The Rockefeller University | Apoptotic cell-mediated antigen presentation to dendritic cells |
| DK1224264T3 (da) | 1999-10-15 | 2010-05-10 | Baylor Res Inst | Anvendelse af allogene cellelinjer til at belaste antigenpræsenterende celler til at fremkomme med immunresponser |
| US7015205B1 (en) * | 1999-10-18 | 2006-03-21 | St. Vincent's Hospital And Medical Center Of New York | Melanoma vaccine and methods of making and using same |
| RU2313365C2 (ru) * | 2001-11-29 | 2007-12-27 | Дандрит Байотек А/С | Фармацевтическая композиция для индукции иммунной реакции у человека |
| GB0130720D0 (en) * | 2001-12-21 | 2002-02-06 | Serono Internat S A | Proteins |
| CN1443778A (zh) * | 2002-03-13 | 2003-09-24 | 上海中信国健药业有限公司 | 一种黑色素瘤相关抗原的单克隆抗体及其用途和药物组合物 |
| JP5623004B2 (ja) | 2004-10-25 | 2014-11-12 | ベイラー リサーチ インスティテュートＢａｙｌｏｒ Ｒｅｓｅａｒｃｈ Ｉｎｓｔｉｔｕｔｅ | 熱ショックをかけたメラノーマ細胞体が装填された樹状細胞 |
| KR101374091B1 (ko) | 2005-07-29 | 2014-03-17 | 프로비던스 헬스 앤드 서비시즈, 오레곤 | 수포에 담긴 불완전 리보솜 생성물（ＤＲｉｂｂｌｅ） 및 면역 반응을 자극하기 위해 이를 이용하는 방법 |
| US8076308B2 (en) * | 2005-11-07 | 2011-12-13 | British Columbia Cancer Agency | Inhibition of autophagy genes in cancer chemotherapy |
| MY160857A (en) * | 2006-02-03 | 2017-03-31 | Malaysian Palm Oil Board | A cancer vaccine |
| US20080031900A1 (en) * | 2006-06-30 | 2008-02-07 | Baylor Research Institute | Dendritic Cells Generated Using GM-CSF and Interferon Alpha and Loaded with Heat-Treated and Killed Cancer Cells |
| AR060424A1 (es) | 2007-04-11 | 2008-06-18 | Consejo Nac Invest Cient Tec | Lineas celulares , composiciones para el tratamiento de melanomas que las comprenden procedimientos para preparar las composiciones y metodos de tratamiento |
| GB0713116D0 (en) * | 2007-07-06 | 2007-08-15 | Therapeutics Ltd E | Treatment of melanoma |
| US20090041792A1 (en) * | 2007-07-19 | 2009-02-12 | Istituto Superiore Di Sanita | Dendritic cells, uses therefor, and vaccines and methods comprising the same |
| AU2012325758A1 (en) | 2011-10-20 | 2014-04-24 | Neostem Oncology, Llc | Antigen presenting cancer vaccine with gamma interferon |
-
2012
- 2012-10-22 AU AU2012325758A patent/AU2012325758A1/en not_active Abandoned
- 2012-10-22 HK HK15101635.2A patent/HK1201175A1/xx unknown
- 2012-10-22 CN CN201610301904.7A patent/CN105999249A/zh active Pending
- 2012-10-22 CN CN201280051821.7A patent/CN103957925A/zh active Pending
- 2012-10-22 EP EP12841839.9A patent/EP2768519A4/en not_active Withdrawn
- 2012-10-22 SG SG11201401631VA patent/SG11201401631VA/en unknown
- 2012-10-22 EP EP12842230.0A patent/EP2768534A4/en not_active Withdrawn
- 2012-10-22 CN CN201610218244.6A patent/CN105861437A/zh not_active Withdrawn
- 2012-10-22 WO PCT/US2012/061306 patent/WO2013059784A1/en not_active Ceased
- 2012-10-22 CN CN201510706438.6A patent/CN105288602A/zh active Pending
- 2012-10-22 US US14/352,982 patent/US20140308316A1/en not_active Abandoned
- 2012-10-22 CN CN201280051799.6A patent/CN103917246A/zh active Pending
- 2012-10-22 WO PCT/US2012/061294 patent/WO2013059778A2/en not_active Ceased
- 2012-10-22 CA CA2852960A patent/CA2852960A1/en not_active Abandoned
- 2012-10-22 AU AU2012325764A patent/AU2012325764A1/en not_active Abandoned
- 2012-10-22 HK HK15101637.0A patent/HK1201176A1/xx unknown
- 2012-10-22 KR KR1020147013353A patent/KR20150016200A/ko not_active Withdrawn
- 2012-10-22 JP JP2014537358A patent/JP2014530627A/ja active Pending
- 2012-10-22 US US14/352,983 patent/US9555058B2/en not_active Expired - Fee Related
- 2012-10-22 SG SG11201401632WA patent/SG11201401632WA/en unknown
- 2012-10-22 CA CA2852967A patent/CA2852967A1/en not_active Abandoned
- 2012-10-22 SG SG10201602424RA patent/SG10201602424RA/en unknown
- 2012-10-22 SG SG10201508535RA patent/SG10201508535RA/en unknown
- 2012-10-22 JP JP2014537355A patent/JP2014533938A/ja active Pending
- 2012-10-22 KR KR1020147013355A patent/KR20150004791A/ko not_active Withdrawn
-
2014
- 2014-04-22 IL IL232172A patent/IL232172A0/en unknown
- 2014-04-22 IL IL232173A patent/IL232173A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014530627A5 (https=) | ||
| JP2014533938A5 (https=) | ||
| Hailemichael et al. | Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion | |
| Padte et al. | A glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primates | |
| Alexandrescu et al. | Immunotherapy for melanoma: current status and perspectives | |
| Hope et al. | Striking a balance—cellular and molecular drivers of memory T cell development and responses to chronic stimulation | |
| PL2102331T3 (pl) | Szczepionka przeciwnowotworowa otrzymana z prawidłowych, chemicznie modyfikowanych komórek CD4+ | |
| EA202190587A3 (ru) | Новые пептиды и комбинации пептидов для применения в иммунотерапии гепатоклеточной карциномы (гкк) и других видов рака | |
| JP2021502414A5 (https=) | ||
| MX2020011674A (es) | Peptidos novedosos y acidos nucleicos de los mismos contra tumores tal como los de cancer gastrico y gastrointestinal. | |
| JP2010514455A5 (https=) | ||
| MX2018007295A (es) | Interleucina 10 en la produccion de linfocitos t cd8+especificos para el antigeno y metodos de uso de estos. | |
| PH12020500433A1 (en) | Novel immunotherapy against several tumors, such as lung cancer, including nsclc | |
| MX389568B (es) | Péptidos y uso de los mismos en inmunoterapia contra varios tumores, tales como cáncer de pulmón, que incluye cáncer de pulmón de células no pequeñas (nsclc) | |
| JP2014514927A5 (https=) | ||
| WO2012054509A3 (en) | Discovery of regulatory t cells programmed to suppress an immune response | |
| WO2015035250A3 (en) | Humoral immune response against tumor antigens after treatment with a cancer antigen specific active immunotherapy and its association with improved clinical outcome | |
| Aspord et al. | pDCs efficiently process synthetic long peptides to induce functional virus‐and tumour‐specific T‐cell responses | |
| TR201905447T4 (tr) | Yeni mhc bağımsız tümörle ilişkili antijenler. | |
| JP2015506698A5 (https=) | ||
| US9089593B2 (en) | Dendritic cell tumor injection (DCTI) therapy | |
| Yang et al. | HCA587 protein vaccine induces specific antitumor immunity mediated by CD4+ T-cells expressing granzyme B in a mouse model of melanoma | |
| MX2020004757A (es) | Nuevos peptidos y nueva combinacion de peptidos para el uso en la inmunoterapia contra el carcinoma hepatocelular (chc) y otros tipos de cancer. | |
| RU2012103822A (ru) | Способ генерации антиген-специфических цитотоксических клеток с активностью против клеток рака яичника | |
| Ota et al. | Vaccination of acute leukemia patients with WT1 peptide-pulsed dendritic cells induces immunological and clinical responses: a pilot study |